ANTICANCER AGENT

[wherein each symbol is as described in the DESCRIPTION] or a pharmaceutically acceptable salt thereof.

Saved in:
Bibliographic Details
Main Authors YOSHIMURA, Yoshinobu, KASAI, Masayasu, TAKEDA, Shigemitsu, SHOJI, Yoshimichi
Format Patent
LanguageEnglish
Published 08.10.2020
Subjects
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
DERIVATIVES THEREOF
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SUGARS
Online AccessGet full text

Cover

More Information
Summary:[wherein each symbol is as described in the DESCRIPTION] or a pharmaceutically acceptable salt thereof.
Bibliography:Application Number: US202016907463